CR2 and diffuse large B-cell lymphoma: Our immunohistochemical results show that approximately one-third of DLBCL (and also unclassified BCL) patients lack CD21 expression, with another approximately one-third having low CD21 expression, in agreement with earlier analyses (Nadler et al, 1983; Otsuka et al, 2004).